Skip to main content
. 2023 May-Jun;39(3):829–834. doi: 10.12669/pjms.39.3.6828

Table-II.

Intergroup comparison of clinical efficacy (χ̅±S, n =40).

Group CR PR NR RR
Study group 18 7 9 34(85%)
Control group 13 6 7 26(65%)
χ2 4.27
P 0.04

P <0.05.